Arvelle Therapeutics International GmbH entered into a partnership with Arvato Systems for the serialization of “Cenobamate”, a potential anti-seizure investigational drug in Europe Arvelle set to implement the serialization solution "Arvato CSDB" in accordance to the pharmaceutical EU Falsified Medicines Directive (EU 2016/161) (Arvato Systems) Gütersloh – Arvelle Therapeutics implements the proven and flexible serialization […]
continue reading